Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
27.85 SEK | -0.71% | +0.72% | -46.44% |
Mar. 14 | Carthesian Therapeutics Terminates Genovis AB (Publ.) Licence Agreement | CI |
Feb. 15 | Genovis AB (publ.) Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-46.44% | 168M | |
+0.89% | 12.95B | |
-7.57% | 7.84B | |
+1.27% | 5.5B | |
+0.93% | 4.61B | |
+7.48% | 4.61B | |
-50.17% | 3.4B | |
+9.21% | 2.66B | |
-14.59% | 2.08B | |
+1.38% | 1.79B |
- Stock Market
- Equities
- GENO Stock
- News Genovis AB
- Genovis to Get $1 Million Milestone Payment for Xork Development